萬業企業(600641.SH):擬8.3億元轉讓持有的全部浙江鐠芯21.8539%股權給無錫正芯
格隆匯3月31日丨萬業企業(600641.SH)公佈,公司擬與無錫正芯簽訂《股份收購協議》,將其持有的全部浙江鐠芯21.8539%股權,以人民幣8.3億元轉讓給無錫正芯。股權轉讓後公司將不再持有浙江鐠芯的股權。
本次交易主要基於公司目前的發展規劃,有利於整合和優化公司資產結構。公司持續深耕半導體集成電路裝備與材料領域,通過出售參股公司股權,可進一步優化資源配置,集中力量強化先進工藝的離子注入機臺與關鍵零部件的技術突破,增強在以上領域的競爭優勢。同時,本次交易有利於進一步提升公司資產流動性和現金流,提高研發投入和產能擴張的資金保障能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.